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From January 1996 to December 1998, 90 consecutive
patients with true bifurcation lesions underwent percu-
taneous coronary angioplasty with Wiktor stent implan-
tation in our centers. In 1 group (group I, n  45), a
simple approach (main vessel stenting and balloon an-
gioplasty of the side branch) was pursued. In the other
group (group II, n  45), both the main vessel and the
side branch were stented (“T” technique). There was no
significant difference in clinical and angiographic char-
acteristics between the 2 groups. Angiographic and pro-
cedural successes were 100% and 95.6%, respectively,
in both groups. Angiographic results for the side branch
were better in group II than in group I. In-hospital and
long-term (12 month) major cardiac events were similar
in the 2 groups. Target lesion revascularization was
15.5% in group I and 35.5% in group II (p 0.12). In the
main vessel, restenosis rate was 12.5% in group I and
25% in group II (p 0.15). In the side branch, restenosis
rate was 37.5% in group II and 12.5% in group I (p 
<0.05; odds ratio 2.42; 95% confidence interval 1.05 to
6.26). Event-free probability at 12 months was 61% in
group II and 80% in group I (p  0.10). When dealing
with true bifurcation lesions, a simple strategy is asso-
ciated with a lower risk of restenosis in the side branch.
In contrast, a complex approach does not appear to give
any benefit in terms of early or long-term outcome or
restenosis rate. 2001 by Excerpta Medica, Inc.
(Am J Cardiol 2001;88:1246–1250)
True bifurcation lesions occur in 2% to 16% ofstenoses being considered for percutaneous coro-
nary intervention. Even if treatment of coronary bi-
furcation lesions is no longer a technical challenge,1–7
this area is still in search of a solution able to lower the
incidence of long-term events. Indeed, the available
long-term results report an incidence of restenosis up
to 36%, indicating that stenting a bifurcation leads to
a higher risk of restenosis than stenting a lesion not
involving a bifurcation.8–12 In addition, the frequent
use of target lesion revascularization (TLR) as an end
point for long-term success may miss restenosis of the
side branch, which can be clinically silent.
METHODS
Study patients: This was a prospective nonrandom-
ized study including all 90 consecutive patients with
true bifurcation lesions (with the criteria specified
below), who underwent percutaneous transluminal
coronary angioplasty (PTCA) with Wiktor stent im-
plantation from January 1996 to December 1998 in 3
participating centers. A true bifurcation lesion was
defined as a lesion inducing a narrowing of 50% in
vessel diameter involving both the main vessel and the
side branch. True bifurcation lesions involving a side
branch with a reference diameter of 2.5 mm were
excluded from the study. All patients gave written,
informed consent for the procedure. In addition, at the
time of the initial stent implantation, patients were
informed of the need for an angiography at 6 months
and also a late (12 months) clinical follow-up.
Interventional procedure: Premedication consisted
of 325 mg/day of nonenteric coated oral aspirin, and
ticlopidine 250 mg twice daily beginning at least 2
days before the procedure. A bolus dose of 10,000 U
of heparin was administered after sheath insertion,
with repeat bolus given as needed to maintain an
activated clotting time of approximately 300 seconds.
Patients received intracoronary isosorbide dinitrate
(0.1 to 0.3 mg) before initial and final angiograms to
achieve maximal vasodilatation. All patients under-
went PTCA by the standard technique via the femoral
approach using an 8Fr guiding catheter. After place-
ment of the guiding catheter, 2 wires were introduced
in the distal bed of the 2 branches. After sequential
inflation of a semicompliant balloon in each branch
(using a balloon-to-artery ratio of 1.0), the choice to
employ a stent in only the main vessel or both vessels
was left to the discretion of the operator. In 1 group
(group I), a simple approach was undertaken, i.e,
stenting of the main vessel followed by balloon an-
gioplasty of the side branch through the struts of the
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stent. In the other group (group II), both the main
vessel and the side branch were treated with stent
implantation. The side branch lesion was always
stented using the “T” technique. In particular, T stent-
ing was performed by deploying the first stent in the
side branch (the horizontal segment of the T), then
delivering and deploying the other
stent in the major vessel (the vertical
segment of the T). Finally, a kissing
balloon inflation was performed to
optimize the acute result.2 A Wiktor
stent (Medtronic Interventional Vas-
cular, Kerkrade, The Netherlands)
was used in all patients; this was a
premounted balloon-expandable stent
composed of a single, loose, interdigi-
tating, coil-like tantalum wire (0.125
mm in diameter) formed into a sinu-
soidal wave and configured as a helix.
The crimped stent profile is 1.5 mm
and deployment does not induce any
modification in stent length (14 to 16
mm). After deployment performed at 9
atm, stent expansion was completed
with an additional inflation to a maxi-
mum of 14 atm, until a good angio-
graphic result was obtained.
Postprocedural medication proto-
col: Heparin was discontinued after
the procedure. Ticlopidine 250 mg
twice daily was continued for 1
month together with aspirin 325 mg/
day, which was continued long-term.
Angiographic measurements were
performed with an automated comput-
er-based system (QCA-CMS version
3.0, MEDIS, Leiden, The Nether-
lands). Lesions were characterized ac-
cording to the modified American Col-
lege of Cardiology/American Heart
Association classification.13 Angio-
graphic success was assessed off-line
by a quantitative estimate of the resid-
ual stenosis30% of the lumen diam-
eter within the stent, effectively posi-
tioned at the intended site and by the
gradation of the anterograde flow as a
Thrombolysis In Myocardial Infarc-
tion flow 3 in both the parent vessel
and side branch. Procedural success
was defined as the achievement of an-
giographic success in the absence of
any in-hospital major adverse cardiac
events (i.e., Q-wave or non–Q-wave
myocardial infarction, bypass surgery,
PTCA, and death).
Postprocedure management and
follow-up: After a successful proce-
dure, sheaths were removed in 4 to 6
hours. Follow-up was performed in
all patients by an interview or a tele-
phone conversation with the patient.
Non–Q-wave myocardial infarction was defined as an
elevation in total creatine kinase equal or greater than
twice the normal value without development of any
new pathologic Q wave. Clinical follow-up was ob-
tained at 6 months in all patients. Angiographic fol-
low-up was planned for all patients at 6 months or
TABLE 1 Baseline Clinical Characteristics of the Groups According to Treatment




(n  45) p Value
Age (yrs) 59  10 62  7 0.10
Men/women 37/8 31/14 0.14
Previous myocardial infarction 21 (46.7%) 14 (31.1%) 0.13
Left ventricular ejection fraction (%) 62  12 62  10 0.59
Previous bypass surgery 4 (8.9%) 4 (8.9%) 1.00
Family history of coronary artery disease 20 (44.4%) 16 (35.6%) 0.39
Systemic hypertension 13 (28.9%) 13 (28.9%) 1.00
Diabetes mellitus 10 (22.2%) 13 (29.9%) 0.38
Unstable angina pectoris 8 (17.8) 8 (17.8%) 1.00
Hypercholesterolemia (200 mg/dl) 14 (31.1%) 20 (44.4%) 0.20
Smoking 18 (40%) 20 (44.4%) 0.67
No. of coronary artery narrowed 50% 0.58
1 25 (55.5%) 26 (57.8%)
2 7 (15.5%) 7 (15.5%)
3 13 (29%) 12 (26.7%)
TABLE 2 Angiographic Characteristics of the Lesions According to Treatment




(n  45) p Value
Coronary artery 0.10
LAD diagonal 24 (53.3%) 30 (66.7%)
LC obtuse marginal 17 (37.8%) 8 (17.8%)
Right PDA 4 (8.9%) 7 (15.6%)
Lesion types* 0.16
A 12 (7.2%) 9 (6.0%) 0.44
B1 63 (37.2%) 44 (29.5%) 0.09
B2 78 (46.1%) 76 (51%) 0.30
C 16 (9.5%) 20 (13.4%) 0.17
Thrombus 0 4 (2.8%) 0.83
Calcific deposits 11 (24.4%) 9 (20.0%) 0.61
Quantitative angiography
Vessel size (mm)
Main vessel 3.38  0.20 3.46  0.23 0.10
Side branch 2.73  0.27 2.71  0.17 0.66
Minimal lumen diameter (mm)
Main vessel
Before 0.98  0.33 1.07  0.17 0.06
After 2.81  0.28 2.97  0.28 0.58
Follow-up 2.10  0.51 2.02  0.51 0.19
Side branch
Before 0.84  0.13 0.86  0.12 0.46
After 1.94  0.17 2.36  0.18 0.001
Follow-up 1.53  0.35 1.44  0.40 0.30
Lesion length (mm) 14  2 15  3 0.40
Percent stenosis (%)
Main vessel
Before 71  10 69  5 0.29
After 17  6 14  3 0.001
Follow-up 39  13 42  15 0.12
Side branch
Before 68  6 68  5 0.91
After 29  4 13  5 0.001
Follow-up 44  11 47  13 0.20
*Modified American Heart Association/American College of Cardiology criteria.
LAD  left anterior descending; LC  left circumflex; PDA  posterior descending artery.
CORONARY ARTERY DISEASE/BIFURCATION LESIONS 1247
earlier if there was a clinical indication. Restenosis
was defined as 50% diameter stenosis of the treated
lesion. TLR was defined as any repeat percutaneous
intervention to the target lesion (parent or side branch)
or any coronary bypass graft to the treated vessel
during follow-up.
Statistical analysis: Continuous variables are pre-
sented as mean  1 SD. Differences between groups
were assessed by chi-square analysis for categorical
variables and Student’s t test for continuous variables.
The contribution of all clinical, angiographic, and
procedural variables to the early and late outcome was
evaluated with multivariate logistic regression analy-
sis. Event-free survival curves were calculated using
the Kaplan-Meier method; differences between groups
were tested with the log-rank test statistic. Probability
values 0.05 were considered significant. Data were
analyzed with SPSS 10 for Windows (SPSS Inc.,
Chicago, Illinois).
RESULTS
Clinical characteristics (Table 1): There was no sig-
nificant difference in clinical characteristics between
the 2 groups.
Angiographic and procedural characteristics (Table
2): There were no differences in the treatment strate-
gies in the 3 centers (group I  52.6%, 51.6%, and
47.4%; group II  47.4%, 48.4%, and 53.4%, respec-
tively; p  0.93). There was a trend toward a larger
minimal lumen diameter of the main vessel in group
II. Angiographic and procedural success was 100%
and 95.6%, respectively, in both groups. The proce-
dure for group II needed more stents (2.3  0.5 vs 1.2
 0.4, p  0.004) and took more time (115  52 vs
98  45 minutes, p 0.05) than it did for group I.
Final balloon/artery ratio was similar in the 2 groups
in the parent vessel (1.06  0.04 in group I vs 1.07 
0.05 in group II, p  0.27), but was different in the
side branch (1.03  0.05 in group I vs 1.10  0.05 in
group II, p0.05). Maximal inflation pressure applied
in the 2 groups was similar in the parent vessel (12 
1 in group I vs 12  0.5 in group II, p  0.77) but
different in the side branch (10  0.5 in group I vs 12
 1 in group II, p 0.05). Final kissing balloon
inflation was performed in all group II patients and in
40% in group I (p 0.05). Final minimal lumen
diameter of the side branch was larger in group II.
Furthermore, residual diameter stenosis in both the
main vessel and side branch was greater in group I.
In-hospital and long-term outcome: In-hospital ma-
jor adverse cardiac events were similar in the 2
groups. No patient in the 2 groups experienced death
and/or urgent repeat PTCA or bypass surgery. Non–
Q-wave myocardial infarction occurred in 2 patients
(4.4%) in both groups I and II. At 12 months, the
occurrence of death, bypass surgery, and acute myo-
cardial infarction was similar in the 2 groups. TLR
rate was 15.6% in group I and 35.6% in group II (p 
0.12). All patients with TLR had eventual repeat
PTCA at the main vessel, side branch, or both. Cu-
mulative event-free survival in the 2 groups is shown
in Figure 1 : There was a trend toward a worse late
outcome in group 2 than in group 1 (event-free prob-
ability at 12 months, 61% vs 80%; p  0.10).
Angiographic follow-up (Table 3) was performed
in 40 patients (90%) in both groups at 8  2 months
(range 3 to 12). There was a trend toward an increase
in restenosis in group II in the main branch (12.5% in
group I and 25% in group II; p  0.15; odds ratio
[OR] 2.33; 95% confidence interval [CI] 0.72 to 7.59)
and a statistically significant difference in the side
branch (37.5% in group II and 12.5% in group I; p 
0.05; OR 2.42; 95% CI 1.05 to 6.26) (Table 3,
Figure 2). Restenosis rate in at least 1 of the 2 vessels
treated was 26.7% in group I and 37.8% in group II (p
 0.25; OR 2.36; 95% CI 1.67 to 4.08). Combined
restenosis of the parent vessel and side branch was
27.5% in group I and 42.5% in group II (p 0.16; OR
2.33; 95% CI 0.72 to 7.59).
DISCUSSION
The main results of our study are that (1) stenting
of bifurcation lesions can be achieved with a high
success rate and an acceptable complication rate, and
(2) stenting of both limbs of bifurcation lesions offers
no advantage (in term of angiographic and clinical
outcome) over stenting of 1 arm and balloon angio-
plasty of the other vessel. Treatment of complex bi-
furcation lesions remains a challenge, even with the
help of stents. In fact, use of a stent has virtually
abolished in-hospital complications, but overall, the
1-year major adverse cardiac event is still 31%, almost
twice the incidence observed for stenting 1 “BE-
NESTENT” (Belgium and Netherlands STENT
Study)-like lesion. These findings suggest a key role
for anatomic factors in the clinical outcome of coro-
nary angioplasty. Not only vessel diameter or lesion
FIGURE 1. Restenosis rate in the main vessel and in the side
branch according to the treatment strategy. Group I (solid line),
1 stent (only in the main vessel) and balloon angioplasty in the
side branch; group II (broken line), 2 stents (both main vessel
and side branch).
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length, but also complex anatomy, such as bifurca-
tions, are related to the likelihood of late events,
notably restenosis.
We failed to demonstrated any significant benefit
of the kissing stents T technique. Although this ap-
proach provides better scaffolding and the best open-
ing of both sides of the bifurcation, such an aggressive
approach is hampered by an higher intimal prolifera-
tion that obviates the initial gain. The “bigger is bet-
ter” concept does not seem to be
valid for the side branch, i.e., a gen-
erally small vessel. The mechanisms
of such an unfavorable outcome for
small vessels are not well under-
stood. Factors proposed are (1) high
degree of vessel stretch and injury,
and (2) high metal density. An ac-
ceptable result with only 1 stent in
the major vessel and no severe resid-
ual stenosis in the side branch not
only is more cost effective, but also
offers a similar clinical outcome.
Previous studies: Our results are in
agreement with recent studies.8–12
Pan et al8 reported that complex
strategies (i.e., deployment of 1 stent
at the ostium of the side branch and
complete reconstruction of the entire
bifurcation with additional implanta-
tion of 1 or 2 stents at the parent
vessel) appear to provide no advan-
tages over the simpler strategy of
deploying just 1 stent in the parent
vessel covering the takeoff of the
side branch followed by ostial side
branch balloon dilation across the
stent’s struts. Yamashita et al10 re-
ported that a complex strategy
(group B) provided no advantage in
terms of procedural success and late outcome versus a
simpler strategy (group P). Stent placement on both
branches resulted in a lower residual stenosis (group B
7.4  10.9% vs group P 23.4%  18.7%; p 0.001)
in the side branch. In-hospital major adverse cardiac
events occurred only in group B (13% vs 0%, p
0.05). At 6 months, the angiographic restenosis rate
(group B 56% vs group P 52%), TLR (37% vs 30%,
respectively) and the incidence of total major adverse
cardiac events were similar. Accordingly, Al Suwaidi
et al12 found no significant differences at 1 year in
survival or the occurrence of myocardial infarction,
coronary artery bypass surgery, or need for repeat
revascularization between complex versus simple
strategy. Patients who had stent deployment in both
arteries had more severe angina and required revascu-
larization more often than those who underwent stent
deployment in 1 arm only. Furthermore, there was a
trend toward better long-term outcome in patients with
stent implantation in only 1 arm.
Study limitations: It may be difficult to assess the
degree of residual stenosis with angiography after
Wiktor stent implantation because of its high ra-
diopacity and possible plaque prolapse. Therefore,
there may be an overestimation of the final lumen
dimension in the stented segments. Practice of sys-
tematic angiographic follow-up can induce a higher
rate of reintervention. However, in all cases, the de-
cision to perform reintervention was based on (1)
clinical status including stress test (when available),
and (2) angiographic severity of restenosis (50%).
FIGURE 2. Event-free survival in the 2 groups. Group I (white
bars), 1 stent (only in the main vessel), and balloon angioplasty
on the side branch; group II (black bars), 2 stents (both main
vessel and side branch).




(n  45) p Value
Main vessel
Gain 1.82  0.51 1.90  0.34 0.48
Late loss 0.72  0.44 0.94  0.55 0.05
Loss index 0.41  0.26 0.47  0.22 0.27
Side branch
Gain 1.09  0.25 1.50  0.22 0.001
Late loss 0.40  0.30 0.91  0.39 0.001
Loss index 0.39  0.32 0.61  0.27 0.001
In hospital MACE
Myocardial infarction 2 (4.4%) 2 (4.4%) 1.00
Coronary bypass 0 0
Death 0 0
Follow-up MACE
Myocardial infarction 0 0 1.00
Coronary bypass 0 1 (2.2%) 0.31
Death 0 0 1.00
Target lesion revascularization
Global 7 (15.6%) 16 (35.6%) 0.12
Main vessel 5 (11.1%) 10 (22.2%)
Side branch 5 (11.1%) 14 (31.1%)
Both 3 (6.7%) 8 (17.8%)
Restenosis rate
Global 11/40 (27.5%) 17/40 (42.5%) 0.16
Main vessels 4/40 (10%) 10/40 (25%)
Side branch 7/40 (17.5%) 15/40 (37.5%)
Both 2/40 (5%) 8/40 (20%)
MACE  major adverse cardiac events.
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